Sundrug Co (9989) Financial Statements

1 Followers

Sundrug Co Financial Overview

Sundrug Co's market cap is currently ¥439.63B. The company's EPS TTM is ¥268.49; its P/E ratio is 14.57; and it has a dividend yield of 3.04%. Sundrug Co is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 26	Mar 25	Mar 24	Mar 23
Income Statement
Total Revenue	¥ 801.81B	¥ 842.51B	¥ 751.78B	¥ 690.46B	¥ 648.73B
Gross Profit	¥ 186.81B	¥ 197.41B	¥ 189.32B	¥ 171.95B	¥ 156.51B
Operating Income	¥ 44.50B	¥ 46.83B	¥ 41.00B	¥ 37.45B	¥ 34.05B
EBITDA	¥ 61.89B	¥ 65.59B	¥ 56.24B	¥ 49.52B	¥ 44.26B
Net Income	¥ 30.75B	¥ 31.39B	¥ 29.13B	¥ 25.70B	¥ 23.85B
Balance Sheet
Cash & Short-Term Investments	¥ 64.96B	¥ 70.52B	¥ 69.70B	¥ 80.87B	¥ 89.33B
Total Assets	¥ 445.08B	¥ 475.50B	¥ 421.31B	¥ 361.72B	¥ 325.77B
Total Debt	¥ 39.48B	¥ 48.22B	¥ 35.85B	¥ 939.00M	¥ 529.00M
Net Debt	¥ -25.48B	¥ -22.31B	¥ -33.84B	¥ -79.93B	¥ -88.80B
Total Liabilities	¥ 175.37B	¥ 189.50B	¥ 168.21B	¥ 125.39B	¥ 105.17B
Stockholders' Equity	¥ 269.71B	¥ 286.00B	¥ 253.09B	¥ 236.33B	¥ 220.59B
Cash Flow
Free Cash Flow	¥ 7.71B	¥ 12.96B	¥ 4.76B	¥ 12.59B	¥ 12.86B
Operating Cash Flow	¥ 41.16B	¥ 43.30B	¥ 41.19B	¥ 37.38B	¥ 31.68B
Investing Cash Flow	¥ -35.37B	¥ -32.08B	¥ -74.85B	¥ -28.51B	¥ -20.66B
Financing Cash Flow	¥ -10.60B	¥ -5.65B	¥ 22.49B	¥ -17.33B	¥ -8.19B

Currency in JPY

Sundrug Co Earnings and Revenue History

Income Statement >

Sundrug Co Debt to Assets

Balance Sheet >

Sundrug Co Cash Flow

Cash Flow >

Sundrug Co Forecast EPS vs Actual EPS

Earnings >